|
Current Drug
Discovery Technologies
ISSN: 1570-1638 - Volume 6, 4 Issues, 2009

Editor-in-Chief:
Vladimir P. Torchilin
Department of Pharmaceutical Science
Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
USA
Editorial Advisory Board:
B.B. Aggarwal (University of Texas MD
Anderson Cancer Center, Texas, USA)
C. Ahlberg (Spotfire, Massachusetts, USA)
G.D. Armstrong (University of Calgary, Calgary,
Alberta, Canada)
A.M. Aronov (Vertex Pharmaceuticals, Inc.,
Cambridge, MA, USA)
Y. Audigier (Institute of Molecular Medecine
of Rangueil, U858 INSERM, France)
D.L. Banville (AstraZeneca Pharmaceuticals,
Wilmington, DE, USA)
J. Bayry (Centre de Recherche des Cordeliers,
Paris, France)
G. Bazylak (Nicolaus Copernicus University,
Bydgoszcz, Poland)
S.J. Benkovic (The Pennsylvania State University, Pennsylvania,
USA)
D. Boison (R.S. Dow Neurobiology
Laboratories, Portland, OR, USA)
M. Braddock (AstraZeneca R&D Charnwood,
Leictershire, UK)
C.R. Bramham (University of Bergen, Bergen,
Norway)
S. Brase (University of Karlsruhe, Karlsruhe,
Germany)
R. Breslow (Columbia University, New York, USA)
M.H. Bronchud (Hospital General of Granollers,
Barcelona, Spain)
M.B. Brown (University of Hertfordshire,
Herts, UK)
R. Bucala (Yale University School of Medicine,
New Haven, CT, USA)
E.A. Castro (Universidad Nacional de La Plata,
La Plata, Argentina)
G.L. Challis (University of Warwick, Coventry,
UK)
K.K. Chan (The Ohio State University, Ohio,
OH, USA)
J.P.F. Chin-Dusting (Baker Heart Research
Institute, Melbourne, Australia)
P. Colas (Station Biologique, Place Georges
Teissier, Roscoff, France)
R.A. Copeland (GlaxoSmithKline, Collegeville,
PA, USA)
R. Cortesi (Ferrara University, Ferrara,
Italy)
M. Crawford (Cerep, Inc., Washington, USA)
M. Cristofanilli (The University of Texas,
Houston, TX, USA)
J.-V. De Julian Ortiz (Polytechnic University
of Valencia, Valencia, Spain)
M.M. De Villiers (University of Wisconsin,
Madison, WI, USA)
U.M.G. Döbbeling (University Hospital
Zurich, Zurich, Switzerland)
J. Drews (Bear Stearns Health Innoventure,
New York, NY, USA)
T.L. Dunckley (Translational Genomics Research
Institute, Phoenix, AZ, USA)
E. Estrada (University of Santiago de Compostela,
Santiago de Compostela, Spain)
Y. Fang (Corning Inc., Corning, NY, USA)
M. Feher (The Campbell Family Institute for
Breast Cancer Research, Toronto, ON, Canada)
W.Y. Feng (Bridge Pharmaceuticals, Beijing,
China)
D.R. Flower (University of Oxford, Berkshire,
UK)
A. Fura (Bristol-Myers Squibb R&D, Princeton,
NJ, USA)
Z.-G. Gao (National Institutes of Health,
Bethesda, MD, USA)
G. Gardiner (Yale University, Connecticut, USA)
L. Ghosez (European Institute of Chemistry and Biology,
France)
J.C. Glorioso (University of Pittsburgh,
Pittsburgh, PA, USA)
B. Gold (National Cancer Institute, Frederick,
MD, USA)
J.A. Grosso (Bristol-Myers Squibb R&D,
Princeton, NJ, USA)
C.P. Hart (Threshold Pharmaceuticals, Redwood
City, CA, USA)
A. Hillisch (Bayer HealthCare AG, Wuppertal,
Germany)
K. Houk (University of California, California, USA)
J. Huard (University of Pittsburgh, Pittsburgh,
PA, USA)
D.W. Hutmacher (National University of Singapore,
Singapore, Singapore)
M. Ishido (National Institute for Environmental
Studies, Tsukuba, Japan)
K. Islam (Arpida, Switzerland)
J.W. Janetka (AstraZeneca R&D Boston,
Waltham, MA, USA)
Z.L. Ji (Xiamen University, Fujian, China)
J. Kardos (Hungarian Academy of Sciences,
Budapest, Hungary)
K. Kariko (University of Pennsylvania School
of Medicine, Philadelphia, PA, USA)
S. Klussmann (Noxxon Pharma AG, Berlin, Germany)
A. Kolb (KeyTech Solutions, Connecticut, USA)
T.A. Kost (GlaxoSmithKline, Research Triangle
Park, NC, USA)
W.A. Korfmacher (Schering-Plough Research
Institute, Kenilworth, NJ, USA)
M. Komada (Tokyo Institute of Technology,
Yokohama, Japan)
M.S. Lajiness (Eli Lilly and Company, Corporate
Circle, Indianapolis, IN, USA)
J.M. Lehn (Nobel Laureate) Institut Le Bel, France)
J.-P. Leonetti (Centre de Pharmacologie et
Biotechnologie pour la Sante, Montpeillier, France)
C. Lipinski (Pfizer Global R&D, Connecticut, USA)
S.A. Lipton (Burnham Institute for Medical
Research, La Jolla, CA, USA)
S. Liu (Schering-Plough Research Institute,
Kenilworth, NJ, USA)
E. Lolis (Yale University, New Haven, CT,
USA)
K. Maggon (Pharma Biotech R&D, Geneva,Switzerland)
M. Maqueda (University of Granada, Granada,
Spain)
C.R. Martin (University of Florida, Gainesville,
FL, USA)
N. Maulik (University of Connecticut School
of Medicine, Farmington, CT, USA)
T.A. McKinsey (University of Colorado, Denver,
CO, USA)
L.K. Minor (Johnson & Johnson Pharmaceutical
R&D, Spring House, PA, USA)
L. Mitscher (University of Kansas, Kansas, USA)
S.M. Moghimi (University of Brighton, Brighton,
UK)
M. Moloney (University of Oxford, Oxford, UK)
R. Morphy (Organon Laboratories Ltd., Motherwell,
UK)
K. Mueller (Hoffman-La Roche Ltd, Switzerland)
D.J. Muller (University of Technology Dresden,
Dresden, Germany)
M. Murcko (Vertex Pharm,Cambridge, MA, USA)
J.P. O'Bryan (University of Illinois College
of Medicine, Chicago, IL, USA)
T. Ochiya (National Cancer Center Research
Institute, Tokyo, Japan)
H. Onishi (Hoshi University, Tokyo, Japan)
E. Paleolog (Imperial College, London, UK)
K.H. Pearce (GlaxoSmithKline, Research Triangle
Park, NC, USA)
R.T. Peterson (Massachusetts General Hospital,
Charlestown, MA, USA)
Y.G. Pommier (National Institutes of Health,
Bethesda, MD, USA)
I.N. Rich (HemoGenix, Inc., Colorado Springs,
CO, USA)
D.D. Root (University of North Texas, Denton,
TX, USA)
A.P. Russ (University of Oxford, Oxford,
UK)
M. Ruvo (University of Naples, Napoli, Italy)
D.K. Sarker (University of Brighton, Brighton,
UK)
J. Schlessinger (Yale University, Connecticut, USA)
K.B. Sharpless (The Scripps Research Institute (TSRI),
California, USA)
P.J. Sinko (Rutgers University, Piscataway,
NJ, USA)
M. Simonyi (Institute of Chemistry, Chemical
Research Center, Budapest, Hungary)
C.P. Sosa (University of Minnesota, Minneapolis,
MN, USA)
M. Spedding (Institute of Research Servier,
Suresnes, France)
L. Stewart (deCODE biostructures Inc., Bainbridge
Island, WA, USA)
G. Subramanian (Sanofi-aventis, New Jersey,
NJ, USA)
K. Sugahara (Hokkaido University Graduate
School of Life Science, Hokkaido, Japan)
D.R. Taft (Long Island University, Brooklyn,
NY, USA)
P. Talaga (UCB Chemin du Foriest, Braine-l'Alleud,
Belgium)
I.V. Tetko (Institute for Bioinformatics,
Neuherberg, Germany)
A.A. Toropov (Institute of Geology &
Geophysics of Academy Science, Tashkent, Republic Uzbekistan)
F. Torrens (University of Valencia, Valencia,
Spain)
G. Trainor (Bristol-Myers Squibb Pharmaceutical, Delaware,
USA)
S.M. Turner (KineMed, Inc., Emeryville, CA,
USA)
J. Vaidyanathan (University of Medicine and
Dentistry of NJ, Newark, NJ, USA)
M.A. Velleca (CGI Pharmaceuticals, Inc.,
Branford, CT, USA)
F. Vinick (Genzyme, Massachusetts, USA)
M.A. Walker (Bristol-Myers Squibb R&D,
Wallingford, CT, USA)
J.J. Wang (Wyeth Pharmaceuticals, Pennsylvania,
USA)
P.A. Wender (Stanford University, California, USA)
L.C. Wienkers (Amgen Inc., Seattle, WA, USA)
M.S. Wolfe (Harvard Medical School, Boston,
MA, USA)
S. Yamagishi (Kurume University School of
Medicine, Kurume, Japan)
A.K. Yudin (University of Toronto, Toronto,
Ontario, Canada)
Y. Zhang (Johns Hopkins University, Baltimore,
MD, USA)
X.F.S. Zheng (UMDNJ-Robert Wood Johnson Medical
School, Piscataway, NJ, USA)
J. Zhou (Acenta Discovery, Inc., Tucson,
AZ, USA) |